Trial intelligence / Profile preview

Omega-3 fatty acids for exercise adaptation in older adults

NCT03350906Phase 3Completed

Sponsor
Mayo Clinic
Start
Jan 2018
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of omega-3 fatty acid in chronic inflammation, muscle disorder, sponsored by Mayo Clinic. Started Jan 2018; status: completed.

02

Drugs

omega-3 fatty acid
03

Conditions

chronic inflammationmuscle disorder

Beyond the preview

Go deeper on NCT03350906.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03350906.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call